Beyond self-monitored plasma glucose and HbA1c

the role of non-traditional glycaemic markers in gestational diabetes mellitus

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Strict glycaemic management is the cornerstone of metabolic control in gestational diabetes mellitus (GDM). Current monitoring standards involve self-monitoring plasma glucose (SMBG) and haemoglobin A1c (HbA1c). However, both have important limitations. SMBG only reflects instantaneous blood glucose and the inconvenience of self-collecting blood frequently results in poor compliance. HbA1c provides information on blood glucose levels from the previous 2 to 3 months and it is influenced by iron-deficient states, common during pregnancy. There is an urgent need for new shorter-term glycaemic markers, as glycated albumin, fructosamine or 1,5-anhydroglucitol. Glycated albumin seems especially interesting as it provides information on blood glucose levels over the foregoing 2-3 weeks and it is not influenced by iron deficiency or the dilutional anaemia of pregnancy. Fructosamine has a precise and inexpensive measurement and it is not affected by haemoglobin characteristics. This review further discusses the potential value of these non-traditional indicators of glycaemic control in patients with GDM, outlining their possible future applications.

Original languageEnglish
Pages (from-to)1-8
Number of pages8
JournalJournal Of Obstetrics And Gynaecology
Volume38
Issue number6
Early online date5 Apr 2018
DOIs
Publication statusPublished - 18 Aug 2018

Fingerprint

Gestational Diabetes
Fructosamine
Blood Glucose
Hemoglobins
Glucose
Iron
Pregnancy
Anemia
glycosylated serum albumin

Keywords

  • 1,5-anhydroglucitol
  • Gestational diabetes mellitus
  • biomarkers
  • fructosamine
  • glycated albumin
  • haemoglobin A1c

Cite this

@article{39a5501537b7458c8f84c180d7bcba88,
title = "Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus",
abstract = "Strict glycaemic management is the cornerstone of metabolic control in gestational diabetes mellitus (GDM). Current monitoring standards involve self-monitoring plasma glucose (SMBG) and haemoglobin A1c (HbA1c). However, both have important limitations. SMBG only reflects instantaneous blood glucose and the inconvenience of self-collecting blood frequently results in poor compliance. HbA1c provides information on blood glucose levels from the previous 2 to 3 months and it is influenced by iron-deficient states, common during pregnancy. There is an urgent need for new shorter-term glycaemic markers, as glycated albumin, fructosamine or 1,5-anhydroglucitol. Glycated albumin seems especially interesting as it provides information on blood glucose levels over the foregoing 2-3 weeks and it is not influenced by iron deficiency or the dilutional anaemia of pregnancy. Fructosamine has a precise and inexpensive measurement and it is not affected by haemoglobin characteristics. This review further discusses the potential value of these non-traditional indicators of glycaemic control in patients with GDM, outlining their possible future applications.",
keywords = "1,5-anhydroglucitol, Gestational diabetes mellitus, biomarkers, fructosamine, glycated albumin, haemoglobin A1c",
author = "Neuza Mendes and {Tavares Ribeiro}, Rog{\'e}rio and F{\'a}tima Serrano",
year = "2018",
month = "8",
day = "18",
doi = "10.1080/01443615.2017.1412409",
language = "English",
volume = "38",
pages = "1--8",
journal = "Journal Of Obstetrics And Gynaecology",
issn = "0144-3615",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Beyond self-monitored plasma glucose and HbA1c

T2 - the role of non-traditional glycaemic markers in gestational diabetes mellitus

AU - Mendes, Neuza

AU - Tavares Ribeiro, Rogério

AU - Serrano, Fátima

PY - 2018/8/18

Y1 - 2018/8/18

N2 - Strict glycaemic management is the cornerstone of metabolic control in gestational diabetes mellitus (GDM). Current monitoring standards involve self-monitoring plasma glucose (SMBG) and haemoglobin A1c (HbA1c). However, both have important limitations. SMBG only reflects instantaneous blood glucose and the inconvenience of self-collecting blood frequently results in poor compliance. HbA1c provides information on blood glucose levels from the previous 2 to 3 months and it is influenced by iron-deficient states, common during pregnancy. There is an urgent need for new shorter-term glycaemic markers, as glycated albumin, fructosamine or 1,5-anhydroglucitol. Glycated albumin seems especially interesting as it provides information on blood glucose levels over the foregoing 2-3 weeks and it is not influenced by iron deficiency or the dilutional anaemia of pregnancy. Fructosamine has a precise and inexpensive measurement and it is not affected by haemoglobin characteristics. This review further discusses the potential value of these non-traditional indicators of glycaemic control in patients with GDM, outlining their possible future applications.

AB - Strict glycaemic management is the cornerstone of metabolic control in gestational diabetes mellitus (GDM). Current monitoring standards involve self-monitoring plasma glucose (SMBG) and haemoglobin A1c (HbA1c). However, both have important limitations. SMBG only reflects instantaneous blood glucose and the inconvenience of self-collecting blood frequently results in poor compliance. HbA1c provides information on blood glucose levels from the previous 2 to 3 months and it is influenced by iron-deficient states, common during pregnancy. There is an urgent need for new shorter-term glycaemic markers, as glycated albumin, fructosamine or 1,5-anhydroglucitol. Glycated albumin seems especially interesting as it provides information on blood glucose levels over the foregoing 2-3 weeks and it is not influenced by iron deficiency or the dilutional anaemia of pregnancy. Fructosamine has a precise and inexpensive measurement and it is not affected by haemoglobin characteristics. This review further discusses the potential value of these non-traditional indicators of glycaemic control in patients with GDM, outlining their possible future applications.

KW - 1,5-anhydroglucitol

KW - Gestational diabetes mellitus

KW - biomarkers

KW - fructosamine

KW - glycated albumin

KW - haemoglobin A1c

U2 - 10.1080/01443615.2017.1412409

DO - 10.1080/01443615.2017.1412409

M3 - Article

VL - 38

SP - 1

EP - 8

JO - Journal Of Obstetrics And Gynaecology

JF - Journal Of Obstetrics And Gynaecology

SN - 0144-3615

IS - 6

ER -